Dr. Carnahan received his BS in Biology and BS in Psychology from Indiana University, jumped into the industry, working for Eli Lilly in both the US and France, then he came back to academia as a researcher at the Institut Pasteur in Paris, France. He completed his Ph.D. in Cell Biology at Vanderbilt University and his post-doc in the laboratory of Al Reynolds, Ph.D. In 2006, he was appointed as Director of the Vanderbilt Antibody and Protein Resource (VAPR). In addition to directing the VAPR, Dr. Carnahan is an Associate Professor in the Cancer Biology, Faculty director of the Management and Entrepreneurship for Scientists program, a member of the Medical School admissions IAC committee, and is a faculty instructor for both M.D. and Ph.D. training programs.  In 2010 he co-founded the Antibody-Technologies Research Group.